Jeremy Millar
Alfred Hospital
CancerInternal medicineRadiologyUrologySurgeryOncologyLogistic regressionRandomized controlled trialIntensive care medicineMedical physicsProstateLung cancerBrachytherapyAndrogen deprivation therapyProstate brachytherapyProstatectomyProstate cancerPopulationNuclear medicinePalliative radiotherapyPopulation based cohortComputer scienceRadiation therapyFamily medicineClinical trialGeneral surgeryMedicineCohort
Publications 49
#1Fanny Sampurno (Monash University)H-Index: 4
#2Justin Cally (Monash University)
Last. Sue Evans (Cancer Council Victoria)
view all 26 authors...
BACKGROUND The Movember funded TrueNTH Global Registry (TNGR) aims to improve care by collecting and analysing a consistent dataset to identify variation in disease management, benchmark care delivery in accordance with best practice guidelines and provide this information to those in a position to enact change. We discuss considerations of designing and implementing a quality of care report for TNGR. METHODS Eleven working group sessions were held prior to and as reports were being built with r...
#1Chad TangH-Index: 32
#2Jeremiah SandersH-Index: 7
Last. Francis J. SullivanH-Index: 15
view all 0 authors...
#1Howard D. ThamesH-Index: 89
#2Chad TangH-Index: 32
Last. Charles CattonH-Index: 71
view all 0 authors...
#1Jack Dalla Via (Baker IDI Heart and Diabetes Institute)H-Index: 4
#1Jack Dalla Via (Baker IDI Heart and Diabetes Institute)
Last. Steve F. FraserH-Index: 19
view all 10 authors...
PURPOSE Androgen deprivation therapy (ADT) for prostate cancer (PCa) has multiple adverse effects on musculoskeletal health. This 12-month randomised controlled trial aimed to assess the effects of multi-component exercise training combined with whey protein, calcium and vitamin D supplementation on bone mineral density (BMD), structure and strength, body composition, muscle strength and physical function in ADT-treated men. METHODS Seventy ADT-treated men were randomised to exercise plus supple...
#1Wee Loon OngH-Index: 7
#2Shankar Siva (University of Melbourne)H-Index: 30
Last. Jeremy Millar (Monash University)H-Index: 5
view all 6 authors...
#1Wee Loon OngH-Index: 7
#2Sue M Evans (Monash University)H-Index: 32
Last. Jeremy Millar (Monash University)H-Index: 5
view all 9 authors...
Abstract Conservative management, specifically with active surveillance (AS), has emerged as the preferred approach for low-risk prostate cancer (LRPC). We evaluated the trend for conservative management (ie, no active treatment within 12 mo of diagnosis) for LRPC in an Australian population-based cohort of men captured in the Prostate Cancer Outcomes Registry Victoria (PCOR-Vic). Of the 3201 men diagnosed with LRPC between January 2009 and December 2016, 60% (1928/3201) had conservative managem...
5 CitationsSource
#1Arun Azad (Monash University)H-Index: 28
#2Ben Tran (WEHI: Walter and Eliza Hall Institute of Medical Research)H-Index: 17
Last. Nathan Papa (Monash University)H-Index: 13
view all 11 authors...
BACKGROUND Docetaxel has emerged as a standard-of-care for metastatic hormone-sensitive prostate cancer (mHSPC). Uptake of docetaxel for mHSPC in Australia has not previously been reported. AIMS i) To investigate the real-world uptake of docetaxel in mHSPC; and ii) To identify predictors of utilisation of Docetaxel in mHSPC. METHODS Men diagnosed from June 2014 to December 2018 and enrolled in the Prostate Cancer Outcomes Registry-Victoria (PCOR-Vic) were included. Data collected includes demogr...
#1Nathan Papa (Monash University)H-Index: 13
#2Marlon Perera (University of Melbourne)H-Index: 21
Last. Damien M Bolton (University of Melbourne)H-Index: 51
view all 7 authors...
INTRODUCTION There has been a growing body of evidence highlighting the improved sensitivity and specificity for prostate specific membrane antigen (PSMA) positron emission tomography (PET) in advanced prostate cancer imaging. We aimed to assess prostate cancer staging practice patterns in Australia using population-based data. SUBJECT AND METHODS We extracted data on men diagnosed with prostate cancer between October 2016 and December 2018 from the Prostate Cancer Outcomes Registry-Victoria (PC...